H.R.7008: Pre-approval Information Exchange Act of 2022

About This Bill

  • This bill was introduced in the 117th Congress
  • This bill is primarily about health
  • Introduced March 9, 2022
  • Latest Major Action March 10, 2022

Bill Cosponsor

Bill Version

Bill Summary

Pre-approval Information Exchange Act of 2022 This bill specifies that economic, scientific, or other product support information that is exchanged between drug manufacturers and health care entities (e.g., pharmacy benefit managers) about drug products before regulatory approval is not considered to be misbranded or prohibited premarket promotion if it relates to the product's investigational use and meets other specified criteria. The...

(Source: Library of Congress)

Bill Actions

Date Description
March 10, 2022
Referred to the Subcommittee on Health.
March 9, 2022
Referred to the House Committee on Energy and Commerce.
March 9, 2022

Introduced in the House by Brett Guthrie (R-Ky.)

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page